WARPTECHNEWS · LAB

Home AI Business Tech Archive

Storia in 17 fonti

Moderna Wavers Despite FDA Win; Will Its Sprint Restart?

Moderna stock wavered Thursday after the Food and Drug Administration approved its mRNA-based flu shot, now called mFlusiva.

Raccontata da

biopharmadive.com

morningstar.com

fiercepharma.com

thestar.com+5 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

investors.comStai leggendo1 g fa

Moderna Wavers Despite FDA Win; Will Its Sprint Restart?

Moderna stock wavered Thursday after the Food and Drug Administration approved its mRNA-based flu shot, now called mFlusiva.

Timeline cronologica

giovedì 6 agosto 2026·biopharmadive.com
FDA approves Moderna’s mRNA flu vaccine
The clearance paves the way for the first preventive flu shot based on mRNA technology and completes a dramatic regulatory turnaround.
giovedì 6 agosto 2026·healio.com
FDA approves first mRNA flu shot, mFlusiva
The FDA has approved the nation’s first messenger RNA-based influenza vaccine, marking a significant development in the fight against the respiratory illness — and the end of a…

fiercepharma.com

1 g fa

Moderna's mRNA flu shot mFlusiva snags FDA nod after refusal-to-file imbroglio

Despite a major curveball thrown by the FDA earlier this year, Moderna has managed to strike true with a U.S. approval for its mRNA-based influenza vaccine. | Despite a major curveball thrown by the FDA earlier this…

Leggi questa versione → originale

iol.co.za1 g fa

US regulators approve Moderna flu vaccine

The company's first mRNA-based flu vaccine, mFLUSIVA, has been approved for use in all adults age 50 and older

Leggi questa versione → originale

morningstar.com1 g fa

Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA

mFLUSIVA becomes Moderna's fifth approved product globally and fourth FDA-approved productCompany expects supply to be available in select retailers in the coming weeks CAMBRIDGE, MA / ACCESS Newswire / August 5, 2026 /…

Leggi questa versione → originale

arstechnica.com22 h fa

Moderna's mRNA flu shot earns FDA approval after rollercoaster review

Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.

Leggi questa versione → originale

cbsnews.com1 g fa

FDA approves Moderna's mRNA flu vaccine after initial pushback

The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.

Leggi questa versione → originale

giovedì 6 agosto 2026·

statnews.com

FDA approves Moderna’s mRNA flu vaccine, the first to use the technology

The FDA has approved Moderna’s influenza vaccine, the first licensed flu shot made using messenger RNA technology.

giovedì 6 agosto 2026·

nbcnews.com

FDA approves 1st mRNA flu shot, from Moderna

The vaccine, called mFlusiva, was approved for older adults. In trials, it was found to be about 27% more effective than a standard flu shot.

giovedì 6 agosto 2026·

morningstar.com

Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA

mFLUSIVA becomes Moderna's fifth approved product globally and fourth FDA-approved productCompany expects supply to be available in select retailers in the coming weeks CAMBRIDGE,…

giovedì 6 agosto 2026·

cbsnews.com

FDA approves Moderna's mRNA flu vaccine after initial pushback

The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.

giovedì 6 agosto 2026·

abcnews.com

FDA approves Moderna's mRNA seasonal flu vaccine

The Food and Drug Administration approved Moderna's mRNA seasonal flu vaccine on Wednesday.

giovedì 6 agosto 2026·

fiercepharma.com

Moderna's mRNA flu shot mFlusiva snags FDA nod after refusal-to-file imbroglio

Despite a major curveball thrown by the FDA earlier this year, Moderna has managed to strike true with a U.S. approval for its mRNA-based influenza vaccine. | Despite a major…

giovedì 6 agosto 2026·

iol.co.za

US regulators approve Moderna flu vaccine

The company's first mRNA-based flu vaccine, mFLUSIVA, has been approved for use in all adults age 50 and older

giovedì 6 agosto 2026·

thehindu.com

U.S. FDA approves first mRNA flu shot from Moderna

Moderna's mFlusiva becomes the first mRNA flu vaccine approved by the FDA for adults 50 and older.

giovedì 6 agosto 2026·

apnews.com

New kind of flu shot is on the way as the FDA approves Moderna's mRNA-based vaccine

The Food and Drug Administration has approved a new flu vaccine for older people, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic.

giovedì 6 agosto 2026·

thestar.com

New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based vaccine

WASHINGTON (AP) — The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key

giovedì 6 agosto 2026·

investors.com

Moderna Wavers Despite FDA Win; Will Its Sprint Restart?

Moderna stock wavered Thursday after the Food and Drug Administration approved its mRNA-based flu shot, now called mFlusiva.

giovedì 6 agosto 2026·

arstechnica.com

Moderna's mRNA flu shot earns FDA approval after rollercoaster review

Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.

giovedì 6 agosto 2026·

qz.com

FDA approves Moderna's first mRNA flu vaccine mFlusiva

The vaccine, called mFlusiva, is the first mRNA-based flu shot to receive regulatory approval anywhere in the world

giovedì 6 agosto 2026·

cbc.ca

U.S. FDA approves first mRNA flu shot from Moderna | CBC News

Reversing an earlier refusal, the FDA has approved Moderna's first mRNA flu shot for adults 50 and older. Here's what the major decision means as Health Canada considers its own…

giovedì 6 agosto 2026·

vox.com

The flu shot finally gets an upgrade

Moderna’s new mRNA vaccine could improve flu protection, but the holy grail is a universal vaccine.

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia: Moderna Wavers Despite FDA Win; Will Its Sprint Restart? — Warptech Lab News